Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration-Reference-Cited by-同舟云学术

Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration

Published:2020-09-03 Issue:17 Volume:5 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Ott Martina,Tomaszowski Karl-Heinz,Marisetty Anantha,Kong Ling-Yuan,Wei Jun^ORCID,Duna Maya,Blumberg Katia,Ji Xiaorong,Jacobs Carmen,Fuller Gregory N.^ORCID,Langford Lauren A.,Huse Jason T.,Long James P.^ORCID,Hu Jian,Li Shulin,Weinberg Jeffrey S.^ORCID,Prabhu Sujit S.,Sawaya Raymond,Ferguson Sherise,Rao Ganesh,Lang Frederick F.^ORCID,Curran Michael A.^ORCID,Heimberger Amy B.^ORCID

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/134386/files/pdf

Reference27 articles.

1. Pembrolizumab versus Ipilimumab in Advanced Melanoma

2. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

3. Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies

4. PD-L1 expression and prognostic impact in glioblastoma

5. Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy;Bioengineering & Translational Medicine;2024-08-31

2. Interferon regulatory factor 8-driven reprogramming of the immune microenvironment enhances antitumor adaptive immunity and reduces immunosuppression in murine glioblastoma;Neuro-Oncology;2024-08-08

3. Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma;Immunity;2024-05

4. IRF8-driven reprogramming of the immune microenvironment enhances anti-tumor adaptive immunity and reduces immunosuppression in murine glioblastoma;2024-04-03

5. Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer;Journal of Controlled Release;2024-03